出处
《肿瘤》
CAS
CSCD
北大核心
2003年第5期441-443,共3页
Tumor
基金
国家杰出青年科学基金资助项目 (编号 :Y3 0 0 2 5 0 15 )
参考文献21
-
1Normann SJ, Sorkin E. Inhibition of marcophage chemotaxis by neoplasitic and other rapidly proliferating ceils in vitro[J].Cancer Res, 1977,37(3) : 705.
-
2Gasperini S, Marchi M, Calzetti F, et al. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils[J].J Immunol, 1999, 162(8):4928.
-
3Homey B, Muller A, Zlotnik A. Chemokines: agents for the immunotherapy of cancer[J] ? Nature Rev Immunol, 2002,2(3) : 175.
-
4Oppenheim JJ, Murphy WJ, Chertox O, et al. Prospects for cytokine and chemokine biotherapy [J]. Clin Cancer Res,1997,3(12) :2682.
-
5Hogaboam CM, Bone-Larson C, Matsukawa A, et al. Therapeutic use of chemokines[J]. Curr Pharm Des, 2000,6(6):651.
-
6Devora R, Zlotnik A. The biology of ehemokines and their receptors[J]. Annu Rev Immunol, 2000,18:217.
-
7Horuk R. Survey.. Chemokine receptors [J]. Cytokine Growth Factor Rev,2001,12(4) :313.
-
8Gerard C, Rollins BJ. Chemokines and disease[J]. Nat Immunol, 2001,2(2) :108.
-
9Rottman JB. Key role of CXC chemokines and chemokine receptors in inflammation, immunity, neoplasia, and infectious disease[J]. Vet Pathol, 1999,36(5) :357.
-
10Balkwill F, Mantovani A. Inflammation and cancer: back to virehow[J]? Lancet,2001,357(9255) :539.
同被引文献73
-
1Huang, Fan,Geng, Xiao-Ping.Chemokines and hepatocellular carcinoma[J].World Journal of Gastroenterology,2010,16(15):1832-1836. 被引量:20
-
2Elise L,Christophe C,Mutsunori I,et al.Intratumoral CC chemokine ligand 5 overexpression delays tumor growth and increases tumor cell infiltration[J].Immunology, 2004,173(6):3755-3762.
-
3Ioannidis JP, Contopoulos-I DG, Rosenberg PS, et al. Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis[J].AIDS,2003, 17(11):1631-1638.
-
4Yoshihiko Hoshino, Doris B,Tes, Gemma R,et al. Mycobacterium tuberculosis-Induced CXCR4 and Chemokine Expression Leads to preferential X4 HIV-1 replication in human macrophages[J].Immunology, 2004, 172:6251-6258.
-
5Wald O,Pappo O,Safadi R,et al.Involvement of the CXCL12/ CXCR4 pathway in the advanced liver disease that is associated with hepatitis C virus or hepatitis B virus[J].Eur J Immunol,2004,34(4):1164-1174.
-
6Golo A,Rainer PW,Jurgen R,et al.CC-chemokine receptor 5(CCR5) in hepatitis C-at the crossroads of antiviral immune response[J]?Antimicrobial Chemotherapy,2004,53(6):895-898.
-
7Tesfaye Belay, Francis OE, Godwin AA,et al. Chemokine and chemokine receptor dynamics during genital chlamydial infection[J].Infection and Immunity, 2002, 70(2):844-850.
-
8Heather KM,Kathleen AK. Chemokine expression patterns differ within anatomically distinct regions of genital tract during chlamydia trachomatis infection[J].Infection and Immunity, 2002, 70(3):1538-1546.
-
9Mitchell SP, Spencer RH, Don AS,et al. Urethral cytokine and immune response in chlamydia trachomatis infected males[J].Infection and Immunity, 2001, 69(11):7178-7181.
-
10Romagnani P, Lasagni L, Annunziato F, et al. CXC chemokines: the regulatory link between inflammation and angiogenesis[J].TRENDS in Immunology, 2004,25(4):201-209.
引证文献6
-
1桂重阳,余平.趋化因子在感染、肿瘤中的作用[J].医学临床研究,2005,22(4):526-529. 被引量:1
-
2邱智泉,谭蔚锋,张柏和,姜小清.趋化因子CCL20与恶性肿瘤之间的关系[J].肿瘤,2011,31(10):961-963. 被引量:9
-
3邱梅婷,秦松树,覃天,杨兰平,李小林.血清细胞因子及受体在乳腺癌病情及预后判断中的价值[J].山东医药,2014,54(36):14-17. 被引量:13
-
4周玉丽,徐金锋,刘莹莹.趋化因子CCL5及其受体CCR5在乳腺癌中作用的研究进展[J].肿瘤,2015,35(8):920-925. 被引量:8
-
5丁琪,刘昀,张力,刘永忠.双调蛋白过表达促进小鼠肠癌CT26细胞的体内生长[J].肿瘤,2017,37(7):690-699. 被引量:2
-
6张冲,汤玉锐,关翰,汪亚辉,韩兵,姚越,熊言骏,汪盛.基于TCGA数据库探究肾透明细胞癌关键基因的表达及预后作用[J].现代肿瘤医学,2020,28(19):3294-3298.
二级引证文献31
-
1王皓颖,黄尤光,李云峰.趋化因子对肿瘤细胞生物学行为的影响[J].医学综述,2014,20(17):3128-3130. 被引量:4
-
2邱梅婷,秦松树,覃天,杨兰平,李小林.血清细胞因子及受体在乳腺癌病情及预后判断中的价值[J].山东医药,2014,54(36):14-17. 被引量:13
-
3杨小冬,乔俊静,秦艳茹.食管鳞状细胞癌组织中CCL26的表达及其临床意义[J].中国癌症杂志,2015,25(1):13-18. 被引量:4
-
4邱梅婷,秦松树,覃天,杨兰平,李小林.血清细胞因子及相关受体在乳腺癌中的表达及相关性[J].热带医学杂志,2015,15(3):335-338. 被引量:3
-
5张锡贵,李太东,倪武,林育超,毛岸云,车芳,陈海林,刘华强,何春燕.早期乳腺癌保乳手术联合放化疗治疗方案的临床研究[J].中国现代普通外科进展,2015,18(9):709-711. 被引量:16
-
6王静.2型糖尿病乳腺癌患者癌组织中转化生长因子β_1(TGF-β_1)的表达变化[J].糖尿病新世界,2016,19(6):41-42.
-
7魏发强.趋化因子受体4在乳腺癌中的表达及临床意义[J].包头医学院学报,2016,32(7):11-12. 被引量:1
-
8王菀菀,钟春生,孙俊宁,操珍,刘龙,苏文.肺癌患者血清中21种细胞因子的表达水平及其临床意义[J].中国肿瘤生物治疗杂志,2017,24(6):650-655. 被引量:12
-
9张浩永,章宏欣.乳腺癌手术前后EGFR和VEGF表达及意义[J].预防医学,2017,29(7):744-747. 被引量:5
-
10郭智慧,胡清林,杨大学,周庆,蒋安科.乳腺疾病患者血清中肿瘤标志物、细胞因子及唾液酸水平的变化及临床意义[J].现代生物医学进展,2017,17(33):6549-6552. 被引量:16
-
1陈洪芳,卢清军,任鹏.mTOR/P70S6K 信号通路在胃癌中的表达及临床意义[J].中国实用医刊,2014,41(20):16-18. 被引量:3
-
2冯润华,朱正纲.VEGF及其受体与胃癌的关系[J].国外医学(肿瘤学分册),2005,32(2):138-140. 被引量:6
-
3朱欠元.VEGF及其受体与鼻咽癌的关系[J].井冈山大学学报(自然科学版),2006,27(1):84-86.
-
4傅鹰,沈波,余素飞.CXCL10抗肿瘤的效应机制[J].广州医学院学报,2008,36(3):61-64. 被引量:1
-
5彭贵主,吴波,单人锋,周福庆.mTOR/P70S6K信号通路在肝细胞肝癌中的表达及临床意义[J].世界华人消化杂志,2008,16(29):3279-3282. 被引量:14
-
6陈琛,李胜泽.SDF-1/CXCR4生物学轴在宫颈癌中的研究进展[J].中华全科医学,2014,12(3):451-453. 被引量:6
-
7苏征,张灏,李欣,汤华.负载肺癌A549抗原的树突状细胞对细胞因子诱导的杀伤细胞特异性激活研究[J].中国慢性病预防与控制,2008,16(1):23-26. 被引量:2
-
8侯桂琴,鲁照明,穆欣,刘洪涛,刘兰琦,许培荣,薛乐勋,王建人.雷帕霉素靶蛋白信号通路在食管癌细胞系中激活状态的研究[J].中国肿瘤,2007,16(4):260-262. 被引量:3
-
9张哲,王艳红.单核细胞趋化蛋白-1(MCP-1/CCL2)与肿瘤关系的研究进展[J].中国临床医学,2008,15(5):735-737. 被引量:17
-
10唐善浩,裴仁治.趋化因子及其受体与多发性骨髓瘤关系的研究进展[J].临床血液学杂志,2009,22(4):394-397. 被引量:1